There were no substantial differences in demographic or clinicopathologic characteristics by PD-L1 or PD-L2 expression or PD-L1/PD-L2 coexpression, with the exception of stage at SCLC diagnosis (for PD-L1 expression only) and LDH level. Here, PDCD1LG2 is linked to small cell lung carcinoma.